EE483 The Contribution of Innovative Drugs and the National Reimbursement Drug List to Human and Physical Capital in the Social Economy: A Case of Blood Cancer in China
Abstract
Authors
P Qian Z Xu L Geng T Wang H Li C Sun W Tang